Search For "dr nk arora"
High-risk children are priority of COVID-19 vaccination programme
Updated : 4 years ago IST
New Delhi [India], March 15 (ANI): The primary focus was immunisation of children with comorbidities but due to the unavailability of data of such children, we have decided to open immunization for all the children between the age group of 12-15 years, said Dr NK Arora, Chairman of COVID-
Read More
Dr NK Arora advises people not to take COVID-19 'for granted' as China wit
Updated : 4 years ago IST
New Delhi [India], March 15 (ANI): As China is reporting a surge in coronavirus infections, Dr NK Arora, chairman of India's COVID-19 Working Group of NTAGI on Tuesday said that people should not take the disease "for granted" because new variants can occur at all times in future.
Read More
Don't use Molnupiravir for treating COVID-19 in younger population, warns
Updated : 4 years, 2 months ago IST
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
Read More
India likely to witness sharp spike in COVID cases in coming days; vaccina
Updated : 4 years, 2 months ago IST
New Delhi [India], January 11 (ANI): With the high transmissibility of the Omicron variant of COVID-19, India is likely to witness a sharp spike in the number of cases in the coming days, however, following COVID appropriate behaviour and vaccination could help contain the spread of the d
Read More
Covaxin has shown good immune response in children during trials, says Dr
Updated : 4 years, 2 months ago IST
New Delhi [India], December 26 (ANI): Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.
Read More
Policy on booster, additional COVID-19 vaccine doses in two weeks, says Dr
Updated : 4 years, 3 months ago IST
New Delhi [India], November 29 (ANI): With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.
Read More
NTAGI chief Dr Arora calls for social mobilisation campaign for COVID vacc
Updated : 4 years, 4 months ago IST
New Delhi [India], October 22 (ANI): With the country achieved the milestone of administering 100 crore COVID-19 vaccine doses, Dr NK Arora, chairman of the COVID-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI) said a social mobilisation campaign must be run so
Read More
No new COVID-19 variant of concern has emerged, says Dr NK Arora
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): No new variant of concern (VOC) or variant of interest (VOI) of COVID-19 has emerged in the country, said Dr NK Arora, co-chair of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), on Sunday.
Read More
Priority will be children with comorbidities in paediatric COVID vaccine d
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
Read More
There should no vaccine discrimination, Covishield is fully certified, say
Updated : 4 years, 5 months ago IST
New Delhi [India], September 22 (ANI): The United Kingdom has recognised Serum Institute of India-manufactured Covid-19 vaccine Covishield in its new travel rules but has not removed quarantine restrictions concerning Indians.
Read More
Matter of pride for the Indian health system, says NK Arora on crossing 1
Updated : 4 years, 6 months ago IST
New Delhi [India], August 28 (ANI): As India crossed the one crore vaccination mark in a single day on Friday, Dr NK Arora, Chairperson, National Technical Advisory Group on Immunisation in India (NTAGI) working group for COVID vaccination said that the achievement of administering one cr
Read More
No proposal to change Covishield, Covaxin, and Sputnik V dose Interval: NT
Updated : 4 years, 6 months ago IST
New Delhi [India], August 26 (ANI): There is no proposal in consideration to change the dose interval between two COVID-19 vaccines--Covishield, Covaxin, and Sputnik V in India, National Technical Advisory Group on Immunisation's (NTAGI) chairman Dr Nk Arora said on Thursday.
Read More